Top in ID: RSV vaccines for older adults; COVID-19-related fungal infection spike
Click Here to Manage Email Alerts
CDC advisors recommended that older adults talk to their doctors about getting vaccinated against respiratory syncytial virus using one of two recently approved shots.
They said adults aged 60 years or older “may receive” an RSV vaccine — rather than “should” receive one — following “shared clinical decision-making.”
The CDC says its advisory group gives such advice when “broad vaccination” is “unlikely to have population-level impacts.”
It was the top story in infectious disease last week.
Another top story was about new research showing a more than 8% increase in fungal infections in the United States during the COVID-19 pandemic, with higher in-hospital mortality rates for patients with COVID-19-related fungal infections.
Read these and more top stories in infectious disease below:
CDC advisors recommend older adults consider RSV vaccination
CDC vaccine advisors said Wednesday that older adults in the United States should talk to their physicians about getting vaccinated against respiratory syncytial virus. Read more.
US saw heavy toll from fungal infections during COVID-19 pandemic
Hospitalizations that involved fungal infections increased by more than 8% in the United States during the COVID-19 pandemic compared with previous years, researchers found. Read more.
Cloud-based surveillance detects substantial increase in C. auris
Data from a cloud-based surveillance system showed a substantial increase in cases of Candida auris in the United States during a recent 6-month period, researchers reported at ASM Microbe. Read more.
Bespoke phages perform well in small study
In a small study, custom-made bacteriophages produced by a center in Texas either cleared highly resistant bacterial infections or led to clinical improvement in the patient most of the time, researchers reported. Read more.
Two-step testing associated with decreased incidence of hospital-onset C. difficile
Two-step Clostridioides difficile testing was associated with decreased reported incidence of hospital-onset C. difficile infection and C. difficile-specific antibiotic use, researchers found. Read more.